New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base;   - concentrate for injection - 1 mg/ml - active: noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base   excipient: nitrogen sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusions and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - adrenaline acid tartrate 1.8 mg/ml equivalent to 1 mg/ml adrenaline;   - solution for injection - 1 mg/ml - active: adrenaline acid tartrate 1.8 mg/ml equivalent to 1 mg/ml adrenaline   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira enterprises b.v. - noradrenaline acid tartrate - concentrate for soln for inf - 1 mg/ml - adrenergic and dopaminergic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 2 mg/ml (equivalent: noradrenaline (norepinephrine), qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 2 mg/ml (equivalent: noradrenaline (norepinephrine), qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline - solution for injection - 1:10000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - noradrenaline acid tartrate monohydrate 2 mg/ml equivalent to noradrenaline 1 mg/ml;   - solution for injection - 1 mg/ml - active: noradrenaline acid tartrate monohydrate 2 mg/ml equivalent to noradrenaline 1 mg/ml   excipient: sodium chloride sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - noradrenaline acid tartrate monohydrate 2 mg/ml equivalent to noradrenaline base 1 mg/ml - concentrate for injection - 1 mg/ml - active: noradrenaline acid tartrate monohydrate 2 mg/ml equivalent to noradrenaline base 1 mg/ml excipient: sodium chloride sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusions and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 8 mg/ml (equivalent: noradrenaline (norepinephrine), qty 4 mg/ml) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.